Secondary prevention

 

Useful References

Antithrombotic treatment

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M (2011) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. Health Technology Assess. 15(31),1-178.

Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht H (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.  Lancet 364(9431): 331-7.

 

Anticoagulation

Kreuzer J (2011) Update on anti-coagulation in atrial fibrillation. Quarterly Journal of Medicine. 104(9),747-60.

EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.  Lancet 342 (8882): 1255-62.

 

Blood pressure

Lakhan SE, Sapko MT (2009) Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis.  International Archives of Medicine 2(1): 30.

Rothwell PM (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet  375(9718), 938-48.

 

Medication adherence

Brown MT, Bussell JK (2011) Medication adherence: WHO cares? Mayo Clinic Proceedings 86(4),304-14.

 

Lipid-lowering

Nassief A, Marsh JD (2008) Statin therapy for stroke prevention. Stroke 39(3),1042-8.

 

Future risk of stroke

Mant J, Wade D, Winner S (2004) ‘Health care needs assessment: stroke’. In: Stevens A, Raftery J, Mant J, Simpson S (eds) (2004) Health care needs assessment: the epidemiologically based needs assessment reviews. Second edition. Oxford: Radcliffe Medical Press.